Studies Reveal How Merck & Co., Inc.’s Vioxx Raises Heart Risks

After almost 13 years of study and intense debate, researchers have shed light on exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it. It has…
Read the full story: BioSpace.com Featured News